Breaking News, Collaborations & Alliances

GenScript Partners with Harvard to Develop Ultra-safe Cells Resistant to Natural Viruses

Innovation grant will be provided to support George Church's contributions to Genome Project-write's first large-scale initiative

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GenScript, a gene synthesis provider, will provide research support to Harvard University scientist George Church, PhD, for his contributions to the Ultra-safe Cell project, the first grand scale community-wide initiative being undertaken by Genome Project-write and The Center for Excellence in Engineering Biology. The project aims to develop a cell line that is completely resistant to all natural viruses, and consequently could pave the way for many biomedical applications, from modeling cell a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters